TRI LOCUM PARTNERS LP Holdings

TRI LOCUM PARTNERS LP is an investment fund managing more than 364.34M US dollars. The largest holdings include Eli Lilly and Company, Biogen and argenx SE. In Q3 2022 the fund bought assets of total value of 204.04M US dollars and sold assets of total value of 96.47M US dollars.

$364.33M

portfolio value

+8.88%

quarter

-20.43%

1 year

TRI LOCUM PARTNERS LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2021	180946000	142445000
Q2 2021	83404000	157767000
Q3 2021	136540000	160266000
Q4 2021	195316000	158432000
Q1 2022	125526000	118974000
Q2 2022	123082000	136098000
Q3 2022	204044000	96472000

TRI LOCUM PARTNERS LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 9.33% Portfolio value: 34.00M Avg. open price: $307.52 Current price: $369.29 P/L: +20.09% Bought +50.96% shares Q3 2022	share	9.33%	34.00M	$307.52	$369.29	+20.09%	Bought +50.96% shares Q3 2022
Drug Manufacturers—General Biogen Inc. Portfolio share: 6.64% Portfolio value: 24.17M Avg. open price: N/A Current price: $292.75 P/L: N/A N/A Q3 2022	share	6.64%	24.17M	N/A	$292.75	N/A	N/A Q3 2022
Biotechnology argenx SE Portfolio share: 6.22% Portfolio value: 22.64M Avg. open price: $315.31 Current price: $393.21 P/L: +24.70% Sold -22.46% shares Q3 2022	share	6.22%	22.64M	$315.31	$393.21	+24.70%	Sold -22.46% shares Q3 2022
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 5.73% Portfolio value: 20.85M Avg. open price: N/A Current price: $124 P/L: N/A N/A Q3 2022	share	5.73%	20.85M	N/A	$124	N/A	N/A Q3 2022
Biotechnology Regeneron Pharmaceuticals, Inc. Portfolio share: 5.69% Portfolio value: 20.74M Avg. open price: $481.44 Current price: $755.45 P/L: +56.91% N/A Q3 2022	share	5.69%	20.74M	$481.44	$755.45	+56.91%	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Catalent, Inc. Portfolio share: 4.67% Portfolio value: 17.02M Avg. open price: $107.29 Current price: $50.77 P/L: -52.68% Bought +117.40% shares Q3 2022	share	4.67%	17.02M	$107.29	$50.77	-52.68%	Bought +117.40% shares Q3 2022
Diagnostics & Research Guardant Health, Inc. Portfolio share: 4.22% Portfolio value: 15.39M Avg. open price: $40.34 Current price: $51.95 P/L: +28.78% Bought +48.69% shares Q3 2022	share	4.22%	15.39M	$40.34	$51.95	+28.78%	Bought +48.69% shares Q3 2022
Biotechnology Jazz Pharmaceuticals plc Portfolio share: 3.90% Portfolio value: 14.19M Avg. open price: $156.01 Current price: $150.97 P/L: -3.23% Bought +85.71% shares Q3 2022	share	3.90%	14.19M	$156.01	$150.97	-3.23%	Bought +85.71% shares Q3 2022
Medical Devices Edwards Lifesciences Corporation Portfolio share: 3.88% Portfolio value: 14.13M Avg. open price: $111.05 Current price: $73.85 P/L: -33.50% Sold -6.34% shares Q3 2022	share	3.88%	14.13M	$111.05	$73.85	-33.50%	Sold -6.34% shares Q3 2022
Medical Instruments & Supplies Stevanato Group S.p.A. Portfolio share: 3.59% Portfolio value: 13.07M Avg. open price: $20.77 Current price: $15.64 P/L: -24.70% Sold -13.22% shares Q3 2022	share	3.59%	13.07M	$20.77	$15.64	-24.70%	Sold -13.22% shares Q3 2022
Biotechnology Cassava Sciences, Inc. Portfolio share: 3.32% Portfolio value: 12.09M Avg. open price: N/A Current price: $33.74 P/L: N/A N/A Q3 2022	call	3.32%	12.09M	N/A	$33.74	N/A	N/A Q3 2022
Drug Manufacturers—General GSK plc Portfolio share: 3.31% Portfolio value: 12.05M Avg. open price: N/A Current price: $35.16 P/L: N/A N/A Q3 2022	share	3.31%	12.05M	N/A	$35.16	N/A	N/A Q3 2022
Medical Instruments & Supplies Bausch + Lomb Corporation Portfolio share: 2.95% Portfolio value: 10.74M Avg. open price: N/A Current price: $15.21 P/L: N/A N/A Q3 2022	share	2.95%	10.74M	N/A	$15.21	N/A	N/A Q3 2022
Biotechnology Mirati Therapeutics, Inc. Portfolio share: 2.90% Portfolio value: 10.58M Avg. open price: N/A Current price: $92.75 P/L: N/A N/A Q3 2022	share	2.90%	10.58M	N/A	$92.75	N/A	N/A Q3 2022
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 2.90% Portfolio value: 10.55M Avg. open price: N/A Current price: $122.96 P/L: N/A N/A Q3 2022	share	2.90%	10.55M	N/A	$122.96	N/A	N/A Q3 2022
Household & Personal Products The Beauty Health Company Portfolio share: 2.67% Portfolio value: 9.72M Avg. open price: $16.92 Current price: $11.03 P/L: -34.80% Sold -9.74% shares Q3 2022	share	2.67%	9.72M	$16.92	$11.03	-34.80%	Sold -9.74% shares Q3 2022
Biotechnology Allogene Therapeutics, Inc. Portfolio share: 2.32% Portfolio value: 8.46M Avg. open price: $11.4 Current price: $9.37 P/L: -17.81% Bought +188.15% shares Q3 2022	share	2.32%	8.46M	$11.4	$9.37	-17.81%	Bought +188.15% shares Q3 2022
Biotechnology Prometheus Biosciences, Inc. Portfolio share: 2.00% Portfolio value: 7.29M Avg. open price: $37.76 Current price: $37.72 P/L: -0.11% Sold -61.10% shares Q3 2022	share	2.00%	7.29M	$37.76	$37.72	-0.11%	Sold -61.10% shares Q3 2022
Biotechnology Maravai LifeSciences Holdings, Inc. Portfolio share: 1.97% Portfolio value: 7.16M Avg. open price: N/A Current price: $13.34 P/L: N/A N/A Q3 2022	share	1.97%	7.16M	N/A	$13.34	N/A	N/A Q3 2022
Biotechnology Akero Therapeutics, Inc. Portfolio share: 1.96% Portfolio value: 7.12M Avg. open price: N/A Current price: $44.04 P/L: N/A N/A Q3 2022	share	1.96%	7.12M	N/A	$44.04	N/A	N/A Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 1.84% Portfolio value: 6.70M Avg. open price: $26.96 Current price: $36.66 P/L: +35.98% Bought +80.53% shares Q3 2022	share	1.84%	6.70M	$26.96	$36.66	+35.98%	Bought +80.53% shares Q3 2022
Biotechnology Coherus BioSciences, Inc. Portfolio share: 1.68% Portfolio value: 6.12M Avg. open price: $7.24 Current price: $6.74 P/L: -6.91% Bought +69.18% shares Q3 2022	share	1.68%	6.12M	$7.24	$6.74	-6.91%	Bought +69.18% shares Q3 2022
Biotechnology Kezar Life Sciences, Inc. Portfolio share: 1.68% Portfolio value: 6.11M Avg. open price: $8.27 Current price: $7.07 P/L: -14.51% Bought +40.72% shares Q3 2022	share	1.68%	6.11M	$8.27	$7.07	-14.51%	Bought +40.72% shares Q3 2022
Biotechnology Astria Therapeutics, Inc. Portfolio share: 1.57% Portfolio value: 5.70M Avg. open price: N/A Current price: $10.32 P/L: N/A N/A Q3 2022	share	1.57%	5.70M	N/A	$10.32	N/A	N/A Q3 2022
Diagnostics & Research Natera, Inc. Portfolio share: 1.56% Portfolio value: 5.69M Avg. open price: N/A Current price: $40.39 P/L: N/A N/A Q3 2022	share	1.56%	5.69M	N/A	$40.39	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Teva Pharmaceutical Industries Limited Portfolio share: 1.51% Portfolio value: 5.51M Avg. open price: N/A Current price: $8.62 P/L: N/A N/A Q3 2022	share	1.51%	5.51M	N/A	$8.62	N/A	N/A Q3 2022
Biotechnology Xenon Pharmaceuticals Inc. Portfolio share: 1.33% Portfolio value: 4.84M Avg. open price: N/A Current price: $38.83 P/L: N/A Sold -19.27% shares Q3 2022	share	1.33%	4.84M	N/A	$38.83	N/A	Sold -19.27% shares Q3 2022
Biotechnology Ventyx Biosciences, Inc. Portfolio share: 1.20% Portfolio value: 4.36M Avg. open price: N/A Current price: $28.09 P/L: N/A N/A Q3 2022	share	1.20%	4.36M	N/A	$28.09	N/A	N/A Q3 2022
Biotechnology X4 Pharmaceuticals, Inc. Portfolio share: 1.18% Portfolio value: 4.28M Avg. open price: $1.18 Current price: $1.29 P/L: +9.49% Bought +44.05% shares Q3 2022	share	1.18%	4.28M	$1.18	$1.29	+9.49%	Bought +44.05% shares Q3 2022
Medical Devices Inspire Medical Systems, Inc. Portfolio share: 1.14% Portfolio value: 4.15M Avg. open price: N/A Current price: $234.96 P/L: N/A Sold -26.16% shares Q3 2022	share	1.14%	4.15M	N/A	$234.96	N/A	Sold -26.16% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.94% Portfolio value: 3.41M Avg. open price: $6.31 Current price: $21.89 P/L: +246.91% N/A Q3 2022	share	0.94%	3.41M	$6.31	$21.89	+246.91%	N/A Q3 2022
Biotechnology Beam Therapeutics Inc. Portfolio share: 0.70% Portfolio value: 2.56M Avg. open price: N/A Current price: $44.37 P/L: N/A N/A Q3 2022	share	0.70%	2.56M	N/A	$44.37	N/A	N/A Q3 2022
Biotechnology CRISPR Therapeutics AG Portfolio share: 0.65% Portfolio value: 2.38M Avg. open price: N/A Current price: $52.11 P/L: N/A N/A Q3 2022	share	0.65%	2.38M	N/A	$52.11	N/A	N/A Q3 2022
Biotechnology BELLUS Health Inc. Portfolio share: 0.62% Portfolio value: 2.26M Avg. open price: $3.96 Current price: $10.02 P/L: +152.86% Sold -81.08% shares Q3 2022	share	0.62%	2.26M	$3.96	$10.02	+152.86%	Sold -81.08% shares Q3 2022
Biotechnology Altimmune, Inc. Portfolio share: 0.55% Portfolio value: 2.00M Avg. open price: N/A Current price: $11.09 P/L: N/A Sold -72.63% shares Q3 2022	share	0.55%	2.00M	N/A	$11.09	N/A	Sold -72.63% shares Q3 2022
Biotechnology Vaxcyte, Inc. Portfolio share: 0.52% Portfolio value: 1.90M Avg. open price: N/A Current price: $44.33 P/L: N/A N/A Q3 2022	share	0.52%	1.90M	N/A	$44.33	N/A	N/A Q3 2022
Biotechnology Protagonist Therapeutics, Inc. Portfolio share: 0.46% Portfolio value: 1.68M Avg. open price: $31.04 Current price: $7.8 P/L: -74.87% Bought +28.71% shares Q3 2022	call	0.46%	1.68M	$31.04	$7.8	-74.87%	Bought +28.71% shares Q3 2022
Biotechnology FibroGen, Inc. Portfolio share: 0.27% Portfolio value: 967K Avg. open price: N/A Current price: $16.19 P/L: N/A N/A Q3 2022	share	0.27%	967K	N/A	$16.19	N/A	N/A Q3 2022
Biotechnology Arcellx, Inc. Portfolio share: 0.22% Portfolio value: 804K Avg. open price: N/A Current price: $19.45 P/L: N/A N/A Q3 2022	share	0.22%	804K	N/A	$19.45	N/A	N/A Q3 2022
Biotechnology Leap Therapeutics, Inc. Portfolio share: 0.17% Portfolio value: 626K Avg. open price: N/A Current price: $0.52 P/L: N/A N/A Q3 2022	share	0.17%	626K	N/A	$0.52	N/A	N/A Q3 2022
Medical Instruments & Supplies Femasys Inc. Portfolio share: 0.03% Portfolio value: 120K Avg. open price: $2.41 Current price: $1.14 P/L: -52.70% Bought +27.17% shares Q3 2022	share	0.03%	120K	$2.41	$1.14	-52.70%	Bought +27.17% shares Q3 2022
Biotechnology Nektar Therapeutics Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.97 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.97	N/A	Sold -100.00% shares Q3 2022
Advertising Agencies Advantage Solutions Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.15 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.15	N/A	Sold -100.00% shares Q3 2022
Biotechnology Aligos Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.97 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.97	N/A	Sold -100.00% shares Q3 2022
Biotechnology Allakos Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $8.14 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$8.14	N/A	Sold -100.00% shares Q3 2022
Biotechnology Amylyx Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $38.55 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$38.55	N/A	Sold -100.00% shares Q3 2022
REIT—Mortgage Annaly Capital Management, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $7.04 Current price: $21.26 P/L: +201.99% Sold -100.00% shares Q3 2022	share	0.00%	0	$7.04	$21.26	+201.99%	Sold -100.00% shares Q3 2022
Medical Care Facilities Aveanna Healthcare Holdings Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $3.41 Current price: $0.8 P/L: -76.63% Sold -100.00% shares Q3 2022	share	0.00%	0	$3.41	$0.8	-76.63%	Sold -100.00% shares Q3 2022
Software—Infrastructure AvePoint, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $4.83 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$4.83	N/A	Sold -100.00% shares Q3 2022
Biotechnology BioNTech SE Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $170.56 Current price: $166.71 P/L: -2.26% Sold -100.00% shares Q3 2022	share	0.00%	0	$170.56	$166.71	-2.26%	Sold -100.00% shares Q3 2022
Biotechnology CEL-SCI Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.83 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.83	N/A	Sold -100.00% shares Q3 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $20.07 Current price: $51.99 P/L: +159.08% Sold -100.00% shares Q3 2022	share	0.00%	0	$20.07	$51.99	+159.08%	Sold -100.00% shares Q3 2022
Real Estate Services Doma Holdings Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.41 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.41	N/A	Sold -100.00% shares Q3 2022
Health Information Services Evolent Health, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $32 Current price: $28.66 P/L: -10.45% Sold -100.00% shares Q3 2022	share	0.00%	0	$32	$28.66	-10.45%	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Evolus, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $12.99 Current price: $6.98 P/L: -46.27% Sold -100.00% shares Q3 2022	share	0.00%	0	$12.99	$6.98	-46.27%	Sold -100.00% shares Q3 2022
Other Precious Metals & Mining Gatos Silver, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $3.83 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$3.83	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—Specialty & Generic Intra-Cellular Therapies, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $54.25 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$54.25	N/A	Sold -100.00% shares Q3 2022
Farm & Heavy Construction Machinery The Lion Electric Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $3.02 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$3.02	N/A	Sold -100.00% shares Q3 2022
Computer Hardware Markforged Holding Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.07 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.07	N/A	Sold -100.00% shares Q3 2022
Biotechnology Adicet Bio, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $20.2 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$20.2	N/A	Sold -100.00% shares Q3 2022
Gold NovaGold Resources Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $5.95 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$5.95	N/A	Sold -100.00% shares Q3 2022
Biotechnology Revolution Medicines, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $24.32 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$24.32	N/A	Sold -100.00% shares Q3 2022
Health Information Services Science 37 Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.61 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$0.61	N/A	Sold -100.00% shares Q3 2022
Biotechnology Shattuck Labs, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.28 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.28	N/A	Sold -100.00% shares Q3 2022
Education & Training Services Skillsoft Corp. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2	N/A	Sold -100.00% shares Q3 2022
Conglomerates 3M Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $124.63 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$124.63	N/A	Sold -100.00% shares Q3 2022
Biotechnology Travere Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $20.01 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$20.01	N/A	Sold -100.00% shares Q3 2022
Biotechnology Tricida, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $8.71 Current price: $0.23 P/L: -97.38% Sold -100.00% shares Q3 2022	share	0.00%	0	$8.71	$0.23	-97.38%	Sold -100.00% shares Q3 2022
Diagnostics & Research 23andMe Holding Co. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $3.19 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$3.19	N/A	Sold -100.00% shares Q3 2022
Airports & Air Services Wheels Up Experience Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.23 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.23	N/A	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $93.64 Current price: $98.48 P/L: +5.17% Sold -100.00% shares Q3 2022	share	0.00%	0	$93.64	$98.48	+5.17%	Sold -100.00% shares Q3 2022
Oil & Gas Drilling Transocean Ltd. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $3.97 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$3.97	N/A	Sold -100.00% shares Q3 2022

Showing TOP 72 TRI LOCUM PARTNERS LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of TRI LOCUM PARTNERS LP?

The biggest position of the TRI LOCUM PARTNERS LP is Eli Lilly and Company (LLY) with 9.33% portfolio share worth of 34.01M US dollars.

Top 5 TRI LOCUM PARTNERS LP's holdings represent 33.61% of the portfolio:

Eli Lilly and Company (LLY) – 9.33%
Biogen Inc. (BIIB) – 6.64%
argenx SE (ARGX) – 6.22%
Neurocrine Biosciences, Inc. (NBIX) – 5.73%
Regeneron Pharmaceuticals, Inc. (REGN) – 5.69%

Who is the portfolio manager of TRI LOCUM PARTNERS LP?

The portfolio manager of the TRI LOCUM PARTNERS LP is .

What is the total asset value of the TRI LOCUM PARTNERS LP portfolio?

TRI LOCUM PARTNERS LP total asset value (portfolio value) is 364.34M US dollars.

Who is ?

is the portfolio manager of the TRI LOCUM PARTNERS LP.

What is (TRI LOCUM PARTNERS LP) fund performance?

TRI LOCUM PARTNERS LP's quarterly performance is +8.88%, annualy -20.43%.

What is the TRI LOCUM PARTNERS LP CIK?

TRI LOCUM PARTNERS LP's Central Index Key is 0001826434 .